Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Ned Tijdschr Geneeskd ; 145(26): 1229-33, 2001 Jun 30.
Article in Dutch | MEDLINE | ID: mdl-11455686

ABSTRACT

Four patients, three women aged 49, 47 and 74 years, and a man aged 64 years, presented with progressive sensory deficit, pyramidal tract symptoms and postural instability. Tests revealed megaloblastic anaemia and low vitamin B12 levels. Two of the female patients had undergone gynaecological surgery with nitrous oxide anaesthesia, and the male patient had undergone a gastric resection. Subacute combined degeneration of the spinal cord is a neurological disease based on vitamin B12 deficiency. It involves the posterior and lateral columns of the spinal cord, and sometimes the peripheral nerves, the optic nerve or the brain. An MRI scan of the cervical cord revealed abnormalities for three of the four patients. Following parenteral supplementation of vitamin B12, the symptoms and the MRI abnormalities either disappeared or significantly improved. Vitamin B12 deficiency can cause subacute combined degeneration of the cord by interfering with myelin synthesis. As vitamin B12 deficiency is caused by malabsorption in the gastrointestinal tract, oral supplementation is insufficient. It is essential to recognise this treatable disease at an early stage, and not to reject the possible diagnosis if the MRI findings are abnormal. Simple blood tests can lead to the diagnosis and to effective treatment.


Subject(s)
Anemia, Megaloblastic/etiology , Anesthetics/adverse effects , Spinal Cord Diseases/diagnosis , Vitamin B 12 Deficiency/complications , Vitamin B 12/administration & dosage , Aged , Cervical Vertebrae , Female , Humans , Injections, Intramuscular , Magnetic Resonance Imaging , Malabsorption Syndromes/complications , Male , Middle Aged , Myelin Sheath/pathology , Nitrous Oxide/adverse effects , Spinal Cord/pathology , Spinal Cord Diseases/blood , Spinal Cord Diseases/drug therapy , Spinal Cord Diseases/etiology , Spinal Cord Diseases/pathology , Treatment Outcome , Vitamin B 12/blood , Vitamin B 12 Deficiency/blood , Vitamin B 12 Deficiency/drug therapy
2.
Mov Disord ; 11(3): 236-42, 1996 May.
Article in English | MEDLINE | ID: mdl-8723138

ABSTRACT

We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, initial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia-free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased from the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.


Subject(s)
Parkinson Disease/diagnosis , Adult , Aged , Aged, 80 and over , Antiparkinson Agents/adverse effects , Antiparkinson Agents/therapeutic use , Cause of Death , Female , Follow-Up Studies , Humans , Levodopa/adverse effects , Levodopa/therapeutic use , Male , Middle Aged , Neurologic Examination/drug effects , Parkinson Disease/drug therapy , Parkinson Disease/mortality , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...